Measurements and Standards for Cancer Biomarkers in Clinical Testing
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 2468
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer biomarkers have been used to guide clinical decision-making, including risk assessment, screening, diagnosis, treatment selection, the determination of prognosis, the prediction of response to a therapy, and monitoring response and outcomes. Therefore, the accuracy, reliability, and comparability of cancer biomarker measurements is critical and essential if results are to be optimally interpreted for patient care. Standards and reference materials are well-characterized samples that are ensured to be homogenous and stable and accurately reflect the intended analyte. They can be used to ensure that measurement methods are working correctly, to calibrate instruments, to evaluate assay performance, to identify the weaknesses of the measurement process, and to assign values to other materials. Standards and reference materials for cancer biomarkers are highly desired to improve the confidence and reliability of cancer biomarker clinical testing.
This goal of this Special Issue is to present research articles, technical briefs, and scholarly and critical reviews on the topic reflected in the title, “Measurements and Standards for Cancer Biomarkers in Clinical Testing”. We are gathering contributions covering all aspects related to these efforts, including pre-analytical and analytical controls, standards, and reference material development for cancer biomarkers testing. Even though cancer is a disease of the genome, contributions may be related, but not limited, to DNA, RNA, proteins, metabolites, and current and prospective cancer biomarkers in tissue and liquid biopsy.
Dr. Hua-Jun He
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer biomarkers
- measurements
- standards
- reference materials
- standardization
- clinical testing
